EZH2 and diffuse large B-cell lymphoma: In DLBCL and FL, EZH2 catalyzes somatic heterozygous mutations of Y641 and A677 residues in the set domain (44, 59), thereby promoting transcriptional inhibition and tumorigenesis by increasing the level of H3K27me3 (60).